PLEASE READ AND REVIEW THE FOLLOWING TERMS OF USE AGREEMENT CAREFULLY BEFORE USING THE RSS FEED. By accessing this service, you will now receive Web site updates through a RSS reader provided by a third party. By clicking on either the link or the "XML" button on the RSS feed list, you agree to the following Terms of Use Agreement for the RSS feed. If you do not agree, please exit and disregard the information contained herein.

  • You agree not to hold Merck & Co., Inc. responsible for any content provided by any third-party service.
  • Merck & Co., Inc. retains any ownership and other rights in the RSS Content.
  • Use is accompanied by proper attribution to Merck & Co., Inc. as the source (where appropriate).
  • Merck & Co., Inc reserves the right to suspend or terminate this service at any time
  • Terms of Use

Follow Us


Read Dr. Arun Balakumaran’s thoughts on classical Hodgkin lymphoma, #immunooncology & #cancer in young adulthood:… hour 9 min ago
Pleased to share our latest news in classical Hodgkin lymphoma: #immunooncology-1 hour 35 min ago
We're happy to help support a great cause! Thanks for sharing.-2 hours 18 min ago